Harnessing the Power of Precision Medicine – Treating Cancers with Tissue-agnostic Therapies
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...
In 2017, electronic cigarettes (e-cigarettes) were the most commonly used tobacco product among high and middle school students. Many...
The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics,...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved expanding the use of the immunotherapeutic tisagenlecleucel (Kymriah)...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
The U.S. Food and Drug Administration (FDA) recently approved expanding the use of the immunotherapeutic durvalumab (Imfinzi) to include...